Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Diabetes Connections | Type 1 Diabetes cover art

Diabetes Connections | Type 1 Diabetes

Diabetes Connections | Type 1 Diabetes

Written by: Stacey Simms
Listen for free

About this listen
Hosted by award-winning broadcaster and journalist Stacey Simms, Diabetes Connections brings a reporter's perspective to the world of diabetes. Since 2015, Stacey has gone beyond the headlines to ask tough questions, break down the latest research and technology, and share honest conversations with the people shaping diabetes care. From industry leaders and researchers to everyday people living with diabetes, Diabetes Connections delivers the news you need, the stories you love, and the questions you want answered. Smart, engaging, and always focused on the diabetes community.Stacey Simms Media 2015-2026 Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Four Tubeless Pumps in 2027?! CGM studies in older people, new T1D insurance tool, ADA controversy continues, and more!
    Nov 17 2026
    This week on Diabetes Connections In the News… two new tubeless pumps are cleared, a new way to check your diabetes insurance costs and find the right plan, study look at CGM use among older people with diabetes, the ADA Controversy Continues as Research Boycott Grows, and a look at some Diabetes Awareness Month campaigns.. Check out all of our events like Moms' Night Out and Club 1921 here. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Transcript: This week on Diabetes Connections In the News… a new tubeless pump is cleared, a new way to check your diabetes insurance costs and find the right plan, study look at CGM use among older people with diabetes, the ADA Controversy Continues as Research Boycott Grows, and a look at some Diabetes Awareness Month campaigns.. It's all coming up right after this. (AD BREAK) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. We've got a lot to get to, so let's just dive in! Our top story this week: XX Big news – there are now FOUR tubeless insulin pumps FDA cleared. MiniMed Fit and tandem mobi tubeless cleared in the past week – add those to the Beta Bionics Mint and of course, the original, Omnipod. Just yesterday, the FDA cleared the new MiniMed Fit system, which can be worn for up to seven days and holds 300 units of insulin. It has a reusable pump core and a Disposable cartridge – the cannula is built in, so no separate infusion set. Holds 300 units of insulin, with a built-in cannula and reliable adhesive for up to 7 day wear. Reusable pump core — The brains of the pump, this rechargeable part attaches to the disposable cartridge. One charge lasts up to 7 days.The pump uses the same SmartGuard automated insulin delivery technology as MiniMed Flex, adjusting insulin and making corrections every five minutes. The system is fully controlled by smartphone and will be available through pharmacies, with a phased U.S. rollout planned for 2027. https://news.minimed.com/2026-11-16-FDA-Clears-MiniMed-Fit-TM-Worlds-First-and-Only-Tubeless-Insulin-Pump-with-Up-to-Seven-Day-Wear-and-Zero-Interruptions XX Just a few days ago, Tandem Diabetes Care received clearance clearance for a tubeless version of its Mobi insulin pump, with a wearable cartridge and infusion set designed to last up to seven days. Tandem plans a full U.S. launch in the first half of 2027, with distribution exclusively through pharmacies. This gives people with type 1 another potential option for automated insulin delivery without traditional pump tubing. https://www.drugdeliverybusiness.com/tandems-mobi-pump-wins-fda-clearance-for-7-day-tubeless-wearable-set/ In other Tandem news, the company has issued a recall-related correction affecting more than 80,000 Mobi insulin pumps because of a problem that can trigger false occlusion alarms and interrupt insulin delivery. As of late October, Tandem had received reports of 230 adverse events requiring medical attention or hospitalization, although no deaths had been reported. The issue involves friction inside the pump's motor mechanism, which can cause the device to mistakenly detect a blockage. Tandem says customers can continue using their pumps but should respond promptly to alarms, keep a backup insulin delivery method available, and contact customer support if alarms repeatedly interrupt therapy. The company is investigating the problem and working to prevent it in future devices. https://www.medtechdive.com/news/tandem-recalls-mobi-insulin-pump-reports-230-adverse-events/874386/ XX Just in time for open enrollment, a new free tool aims to make choosing health insurance a little less overwhelming for people with diabetes. The GlucoSense Insurance Navigator compares 2027 Marketplace plans based on what you'll actually spend over the course of a year, not just your monthly premium. It factors in deductibles, insulin, CGMs, pump supplies, doctor visits, and even manufacturer savings cards to estimate your total annual costs. The tool's developers say early users have identified plans that could save them thousands of dollars a year. It's available through the GlucoSense app, although you'll still want to confirm...
    Show More Show Less
    14 mins
  • Finding Diabetes Joy: How Poetry Helped Ephraim Navigate a T1D Diagnosis
    Nov 13 2026

    In this bonus episode of Diabetes Connections, meet Ephraim Sommers, an English professor and poet diagnosed with LADA (a slower-developing form of type 1 diabetes) in his early 40s.

    Even though his father has type 1, Ephraim wasn't prepared for the fear, anxiety, and mental load of managing diabetes himself.

    So he turned to poetry. Every weekday, he sat in a coffee shop and wrote about gratitude. Those poems became Diabetic Gumdrops, a new book about finding joy while living with diabetes.

    We talk about shifting from fear to gratitude, advocating for yourself, and why poetry might help even if you haven't read a poem since high school.

    Plus, Ephraim lives right here in the Charlotte area! We had a great time talking about the local T1D community and how important connection can be.

    Check out all of our events like Moms' Night Out and Club 1921 here.

    Announcing Community Commericals! Learn how to get your message on the show here.


    Learn more about studies and research at Thrivable here


    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    25 mins
  • Can a 100-Old Vaccine Impact Type 1 Diabetes? A Conversation with Dr. Denise Faustman
    Nov 10 2026

    This week on Diabetes Connections - looking into a very old vaccine to get new results for people with type 1. Dr. Denise Faustman's research into the BCG vaccine has been making headlines for a long time, and she's now sharing new results from her clinical trials, including some pretty remarkable claims about A1C, insulin use, and time in range.

    Now, I know some of you may be surprised that I'm having Dr. Faustman on the show. She's a very controversial figure in the diabetes research world, and her work has sparked plenty of debate and skepticism over the years.

    We're not ignoring any of that. In fact, we talk directly about the controversy, why she believes her research has faced resistance, and what it would take for BCG to become a widely accepted treatment.

    This podcast is not intended as medical advice if you have those kinds of questions please contact your healthcare provider.

    More about Dr. Faustman's work here

    More about the controversy and history here

    Check out all of our events like Moms' Night Out and Club 1921 here.

    Announcing Community Commericals! Learn how to get your message on the show here.
    Learn more about studies and research at Thrivable here
    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    39 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet